Antitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-14320-0.pdf
Reference33 articles.
1. Iliescu, L. et al. Management of hepatocellular carcinoma - experience of a single center. Chirurgia (Bucur). 109(2), 204–207 (2014).
2. Fitzmorris, P., Shoreibah, M., Anand, B. S. & Singal, A. K. Management of hepatocellular Carcinoma. J Cancer Res Clin Oncol. 141(5), 861–876 (2015).
3. Varo, P. E. & Castroagudin, J. F. The future of liver transplantation. Trannsplant Proc. 42(2), 613–616 (2010).
4. Andreou, A. et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 17(1), 66–77 (2013).
5. Cheng, Z. et al. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. HPB (Oxford). 17(5), 422–427 (2015).
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathways;European Journal of Pharmacology;2024-08
2. Strategies to prolong drug retention in solid tumors by aggregating Endo-CMC nanoparticles;Journal of Controlled Release;2023-08
3. PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-04
4. A 3D-printed PCL/PEI/DNA bioactive scaffold for chemotherapy drug capture in vivo;International Journal of Biological Macromolecules;2023-05
5. CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinβ1;BMC Cancer;2022-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3